AdaptDx Pro Testing Can Help Improve Patient Outcomes
The AdaptDx Pro® is a simple, fully automated dark adaptometer. It measures dark adaptation speed, which can be used to identify age-related macular degeneration (AMD) with 90% sensitivity.
Integrate AdaptDx Pro into Your Practice Through Our AMD Excellence Program
Adding dark adaptation testing to your patient evaluations may help you detect the earliest signs of AMD and can be done seamlessly. Following best practices for optimizing AMD care, our Practice Management Consultant (PMC) will help incorporate dark adaptation testing into your practice protocol and transform your clinic through the AMD Excellence Program®.
The portable design and light-proof seal mean no additional space or dedicated darkroom is required. It’s as simple as adding a step or two to the routine of each team member.
Manages patient scheduling to ensure smooth flow and operation of the office and identifies patients on the schedule over a certain age for a comprehensive eye exam.
Patient Work Up
Administers the AdaptDx Pro dark adaptation test to all patients over a certain age during their comprehensive eye exam.
May work on other tests while Theia™, the onboard AI technician, takes over.
Enters test results into the EHR.
Interprets AdaptDx Pro results.
If the Rod Intercept® is < 6.5 minutes, schedule an AdaptDx Pro as part of their annual routine eye exam.
If the Rod Intercept is ≥ 6.5 minutes, schedule the patient for an Extended Test to obtain a baseline. Once established, schedule the patient for appropriate monitoring of disease progression – every 3-6 months – depending on the severity of the disease.
Meet Theia: Your On-Board Technician
Listen to how Theia guides your patients through the testing—even adapting as they progress.
The AdaptDx Pro is a tool, that not only to gives you hope for better patient outcomes, which is the most important thing, but also helps you to grow your practice. There’s a huge opportunity because AMD is more prevalent than glaucoma, diabetes, and diabetic retinopathy combined.